NCT00375453View on ClinicalTrials.gov

Dose Escalation Study of SH U04722 in Solid Tumors

PHASE1TerminatedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions

Tumors

Interventions

DRUG

SH U04722

Trial Locations (3)

350-1298

Hidaka-shi

350-0495

Iruma-gun

135-8850

Koutou-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY